Changes in the classification and management of skin and soft tissue infections
Open Access
- 1 December 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 66 (2), 232-234
- https://doi.org/10.1093/jac/dkq443
Abstract
Although skin and soft tissue infections (SSTIs) are extremely common in both primary and secondary care, there is a lack of validated evidence-based schemes for the classification of clinical presentation or severity, and there are few data available on treatment outcomes. The commonly used ‘Eron classification’ is based on the consensus views of an expert panel, while the Clinical Resource Efficiency Support Team (CREST) ‘Guidelines on the Management of Cellulitis in Adults’ have not been validated in clinical trials. In the current issue of JAC, investigators at Ninewells Hospital in Dundee, Scotland, report a retrospective study of patients with SSTIs who were treated with antibiotics. The patients were stratified into four classes of clinical severity, based on the presence or absence of sepsis and co-morbidity, and their standardized early warning score. The empirical treatment received by patients in each class was compared with the recommendations of the CREST guidelines. The findings do not make comfortable reading. Overall, 43% of patients (and 65% at the mildest end of the clinical spectrum) were overtreated, while mortality (at 30 days) and inadequate antimicrobial therapy increased with severity class. Strikingly, 35 different empirical antimicrobial prescribing regimens were noted. These findings, which are likely to reflect the situation in many hospitals, show that SSTIs remain a significant cause of mortality and that empirical therapy is bordering on the haphazard, with significant under treatment of severely ill patients.Keywords
This publication has 10 references indexed in Scilit:
- Severity assessment of skin and soft tissue infections: cohort study of management and outcomes for hospitalized patientsJournal of Antimicrobial Chemotherapy, 2010
- Developments in outpatient parenteral antimicrobial therapy (OPAT) for Gram-positive infections in Europe, and the potential impact of daptomycinJournal of Antimicrobial Chemotherapy, 2009
- Development of teicoplanin dosage guidelines for patients treated within an outpatient parenteral antibiotic therapy (OPAT) programmeJournal of Antimicrobial Chemotherapy, 2009
- Daptomycin: rationale and role in the management of skin and soft tissue infectionsJournal of Antimicrobial Chemotherapy, 2008
- Clinical and Economic Consequences of Failure of Initial Antibiotic Therapy for Hospitalized Patients With Complicated Skin and Skin-Structure InfectionsInfection Control & Hospital Epidemiology, 2008
- Bacterial Skin and Soft Tissue Infections in Adults: A Review of Their Epidemiology, Pathogenesis, Diagnosis, Treatment and Site Of CareCanadian Journal of Infectious Diseases and Medical Microbiology, 2008
- Prediction of in-hospital mortality and length of stay using an early warning scoring system: clinical auditClinical Medicine, 2006
- Managing skin and soft tissue infections: expert panel recommendations on key decision pointsJournal of Antimicrobial Chemotherapy, 2003
- Cost-minimization analysis and audit of antibiotic management of bone and joint infections with ambulatory teicoplanin, in-patient care or outpatient oral linezolid therapy.Journal of Antimicrobial Chemotherapy, 2003
- Verlauf, Kosten und Komplikationen bei oraler im Vergleich zu intravenöser Penicillin-Therapie bei ErysipelInfection, 1984